您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Ecopipam
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Ecopipam
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Ecopipam图片
CAS NO:112108-01-7
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
Sch 39166
产品介绍
Ecopipam (SCH 39166) 是一种有效的、选择性、具有口服活性的多巴胺D1/D5受体拮抗剂,Ki值分别为 1.2 nM 和 2.0 nM。Ecopipam 对 D2、D4、5-HT 和 α2a 受体 (Ki=0.98,5.52,0.08 和 0.73 μM) 显示出超过 40 倍的选择性。Ecopipam 可用于精神分裂症、可卡因成瘾和肥胖症的研究。
生物活性

Ecopipam (SCH 39166) is a potent, selective and orally active antagonist ofdopamine D1/D5 receptor, withKis of 1.2 nM and 2.0 nM, respectively. Ecopipam shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a receptor (Ki=0.98, 5.52, 0.08, and 0.73 μM, respectively). Ecopipam can be used for the research of schizophrenia, cocaine addition, and obesity[1][3].

IC50& Target[1]

D1Receptor

1.2 nM (Ki)

D5Receptor

2.0 nM (Ki)

D2Receptor

980 nM (Ki)

D4Receptor

5520 nM (Ki)

5-HT Receptor

80 nM (Ki)

Alpha-2A adrenergic receptor

731 nM (Ki)

体外研究
(In Vitro)

Ecopipam (2 μM) completely abolishes the proconvulsive effect of Dopamine (10 μM) in isolated corticohippocampal formation[2].

体内研究
(In Vivo)

Ecopipam (0.003-0.3 mg/kg; a single s.c.) abolishes Nicotine-induced enhancement of a sensory reinforcer in adult rats[3].
Ecopipam (10, mg/kg, oral administration) antagonizes Apomorphine-induced stereotypy in rats[4].
Ecopipam (5 and 10 μM, perfusion, 1 μL/min) reversibly and dose-dependently decreases acetylcholine release in the rat striatum[5].

Animal Model:Male young adult Long-Evans rats injected with Nicotine[3]
Dosage:0.003, 0.01, 0.03, 0.1, 0.3 mg/kg
Administration:A single s.c. 20 min before Nicotine (0.1 mg/kg)
Result:Dose-dependently reduced pressing on both active and inactive levers.
Clinical Trial
分子量

313.82

Formula

C19H20ClNO

CAS 号

112108-01-7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.